$PHLI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PACIFICHEALTH LABORATORIES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PACIFICHEALTH LABORATORIES INC. Get notifications about new insider transactions in PACIFICHEALTH LABORATORIES INC for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 14 2011 | PHLI | PACIFICHEALTH LABO ... | KUCHEN STEPHEN P | CFO | Option Exercise | A | 0.19 | 80,000 | 15,200 | 80,000 | |
May 13 2011 | PHLI | PACIFICHEALTH LABO ... | Feldman Lee | Director | Option Exercise | P | 0.38 | 20,000 | 7,600 | 20,000 | |
May 13 2011 | PHLI | PACIFICHEALTH LABO ... | Feldman Lee | Director | Option Exercise | P | 0.31 | 100,000 | 31,000 | 100,000 | |
May 13 2011 | PHLI | PACIFICHEALTH LABO ... | Feldman Lee | Director | Buy | P | 0.25 | 200,000 | 50,000 | 400,000 | 200 K to 400 K (+100.00 %) |
May 13 2011 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Option Exercise | P | 0.38 | 20,000 | 7,600 | 20,000 | |
May 13 2011 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Option Exercise | P | 0.31 | 100,000 | 31,000 | 100,000 | |
May 13 2011 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Buy | P | 0.25 | 200,000 | 50,000 | 885,405 | 685.4 K to 885.4 K (+29.18 %) |
May 13 2011 | PHLI | PACIFICHEALTH LABO ... | Duffner Frederick G | President and CEO | Option Exercise | P | 0.38 | 10,000 | 3,800 | 10,000 | |
May 13 2011 | PHLI | PACIFICHEALTH LABO ... | Duffner Frederick G | President and CEO | Option Exercise | P | 0.31 | 50,000 | 15,500 | 50,000 | |
May 13 2011 | PHLI | PACIFICHEALTH LABO ... | Duffner Frederick G | President and CEO | Buy | P | 0.25 | 100,000 | 25,000 | 862,857 | 762.9 K to 862.9 K (+13.11 %) |
May 13 2011 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Director | Option Exercise | P | 0.38 | 40,000 | 15,200 | 40,000 | |
May 13 2011 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Director | Option Exercise | P | 0.31 | 200,000 | 62,000 | 200,000 | |
May 13 2011 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Director | Buy | P | 0.25 | 400,000 | 100,000 | 2,936,854 | 2.5 M to 2.9 M (+15.77 %) |
May 09 2011 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Grant | A | 0.25 | 51,152 | 12,788 | 685,405 | 634.3 K to 685.4 K (+8.06 %) |
Mar 23 2011 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Director | Option Exercise | P | 0.38 | 38,000 | 14,440 | 38,000 | |
Mar 23 2011 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Director | Option Exercise | P | 0.31 | 190,000 | 58,900 | 190,000 | |
Mar 23 2011 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Director | Buy | P | 0.25 | 380,000 | 95,000 | 2,536,854 | 2.2 M to 2.5 M (+17.62 %) |
Mar 23 2011 | PHLI | PACIFICHEALTH LABO ... | Duffner Frederick G | President and CEO | Option Exercise | P | 0.38 | 10,000 | 3,800 | 10,000 | |
Mar 23 2011 | PHLI | PACIFICHEALTH LABO ... | Duffner Frederick G | President and CEO | Option Exercise | P | 0.31 | 50,000 | 15,500 | 50,000 | |
Mar 23 2011 | PHLI | PACIFICHEALTH LABO ... | Duffner Frederick G | President and CEO | Buy | P | 0.25 | 100,000 | 25,000 | 762,857 | 662.9 K to 762.9 K (+15.09 %) |
Dec 13 2010 | PHLI | PACIFICHEALTH LABO ... | KUCHEN STEPHEN P | CFO | Option Exercise | A | 0.18 | 150,000 | 27,600 | 150,000 | |
Nov 30 2010 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Director | Gift | G | 0.00 | 249,683 | 0 | 2,156,854 | 2.4 M to 2.2 M (-10.38 %) |
Oct 01 2010 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Director | Grant | A | 0.00 | 40,000 | 0 | 2,406,547 | 2.4 M to 2.4 M (+1.69 %) |
Oct 01 2010 | PHLI | PACIFICHEALTH LABO ... | PARTICELLI MARC | Director | Grant | A | 0.00 | 40,000 | 0 | 485,807 | 445.8 K to 485.8 K (+8.97 %) |
Oct 01 2010 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Grant | A | 0.00 | 40,000 | 0 | 634,253 | 594.3 K to 634.3 K (+6.73 %) |
Jul 01 2010 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Director | Grant | A | 0.00 | 73,171 | 0 | 2,366,547 | 2.3 M to 2.4 M (+3.19 %) |
Sep 01 2010 | PHLI | PACIFICHEALTH LABO ... | Duffner Frederick G | CEO and President | Option Exercise | A | 0.15 | 250,000 | 36,250 | 700,000 | |
Jul 01 2010 | PHLI | PACIFICHEALTH LABO ... | PORTMAN DAVID I | Director | Grant | A | 0.00 | 36,585 | 0 | 633,859 | 597.3 K to 633.9 K (+6.13 %) |
Jul 01 2010 | PHLI | PACIFICHEALTH LABO ... | PARTICELLI MARC | Director | Grant | A | 0.00 | 73,171 | 0 | 445,807 | 372.6 K to 445.8 K (+19.64 %) |
Jul 01 2010 | PHLI | PACIFICHEALTH LABO ... | Mizel Adam | Director | Grant | A | 0.00 | 73,171 | 0 | 376,753 | 303.6 K to 376.8 K (+24.10 %) |
Jul 01 2010 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Grant | A | 0.00 | 73,171 | 0 | 594,253 | 521.1 K to 594.3 K (+14.04 %) |
Apr 01 2010 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Director | Grant | A | 0.00 | 70,558 | 0 | 2,293,376 | 2.2 M to 2.3 M (+3.17 %) |
Apr 01 2010 | PHLI | PACIFICHEALTH LABO ... | PORTMAN DAVID I | Director | Grant | A | 0.00 | 35,294 | 0 | 597,274 | 562 K to 597.3 K (+6.28 %) |
Apr 01 2010 | PHLI | PACIFICHEALTH LABO ... | PARTICELLI MARC | Director | Grant | A | 0.00 | 70,588 | 0 | 372,636 | 302 K to 372.6 K (+23.37 %) |
Apr 01 2010 | PHLI | PACIFICHEALTH LABO ... | Mizel Adam | Director | Grant | A | 0.00 | 70,588 | 0 | 303,582 | 233 K to 303.6 K (+30.30 %) |
Apr 01 2010 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Grant | A | 0.00 | 70,588 | 0 | 521,082 | 450.5 K to 521.1 K (+15.67 %) |
Mar 11 2010 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Director | Grant | A | 0.00 | 32,966 | 0 | 2,222,788 | 2.2 M to 2.2 M (+1.51 %) |
Jan 05 2010 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Director | Grant | A | 0.00 | 21,429 | 0 | 2,189,822 | 2.2 M to 2.2 M (+0.99 %) |
Jan 05 2010 | PHLI | PACIFICHEALTH LABO ... | PARTICELLI MARC | Director | Grant | A | 0.00 | 42,857 | 0 | 302,048 | 259.2 K to 302 K (+16.53 %) |
Jan 05 2010 | PHLI | PACIFICHEALTH LABO ... | PORTMAN DAVID I | Director | Grant | A | 0.00 | 21,429 | 0 | 561,980 | 540.6 K to 562 K (+3.96 %) |
Jan 05 2010 | PHLI | PACIFICHEALTH LABO ... | Mizel Adam | Director | Grant | A | 0.00 | 42,857 | 0 | 232,994 | 190.1 K to 233 K (+22.54 %) |
Jan 05 2010 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Grant | A | 0.00 | 42,857 | 0 | 450,494 | 407.6 K to 450.5 K (+10.51 %) |
Oct 02 2009 | PHLI | PACIFICHEALTH LABO ... | PORTMAN DAVID I | Director | Grant | A | 0.00 | 11,539 | 0 | 540,551 | 529 K to 540.6 K (+2.18 %) |
Oct 02 2009 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Director | Grant | A | 0.00 | 11,539 | 0 | 2,168,393 | 2.2 M to 2.2 M (+0.53 %) |
Oct 02 2009 | PHLI | PACIFICHEALTH LABO ... | PARTICELLI MARC | Director | Grant | A | 0.00 | 23,077 | 0 | 259,191 | 236.1 K to 259.2 K (+9.77 %) |
Oct 02 2009 | PHLI | PACIFICHEALTH LABO ... | Mizel Adam | Director | Grant | A | 0.00 | 23,077 | 0 | 190,137 | 167.1 K to 190.1 K (+13.81 %) |
Oct 02 2009 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Grant | A | 0.00 | 23,077 | 0 | 407,637 | 384.6 K to 407.6 K (+6.00 %) |
Sep 09 2009 | PHLI | PACIFICHEALTH LABO ... | Mizel Adam | Director | Buy | P | 0.25 | 5,000 | 1,250 | 167,060 | 162.1 K to 167.1 K (+3.09 %) |
Sep 09 2009 | PHLI | PACIFICHEALTH LABO ... | Mizel Adam | Director | Buy | P | 0.24 | 5,000 | 1,200 | 162,060 | 157.1 K to 162.1 K (+3.18 %) |
Aug 21 2009 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Director | Sell | S | 0.32 | 50,000 | 16,000 | 2,156,854 | 2.2 M to 2.2 M (-2.27 %) |
Aug 21 2009 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Director | Sell | S | 0.31 | 100,000 | 30,650 | 2,206,854 | 2.3 M to 2.2 M (-4.33 %) |
Aug 21 2009 | PHLI | PACIFICHEALTH LABO ... | KUCHEN STEPHEN P | CFO | Buy | P | 0.30 | 5,000 | 1,500 | 25,696 | 20.7 K to 25.7 K (+24.16 %) |
Jul 24 2009 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Director | Gift | G | 0.00 | 53,571 | 0 | 2,306,854 | 2.4 M to 2.3 M (-2.27 %) |
Jul 01 2009 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Director | Grant | A | 0.00 | 20,000 | 0 | 2,360,425 | 2.3 M to 2.4 M (+0.85 %) |
Jul 01 2009 | PHLI | PACIFICHEALTH LABO ... | PORTMAN DAVID I | Director | Grant | A | 0.00 | 10,000 | 0 | 529,012 | 519 K to 529 K (+1.93 %) |
Jul 01 2009 | PHLI | PACIFICHEALTH LABO ... | Mizel Adam | Director | Grant | A | 0.00 | 20,000 | 0 | 157,060 | 137.1 K to 157.1 K (+14.59 %) |
Jul 01 2009 | PHLI | PACIFICHEALTH LABO ... | PARTICELLI MARC | Director | Grant | A | 0.00 | 20,000 | 0 | 236,114 | 216.1 K to 236.1 K (+9.25 %) |
Jul 01 2009 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Grant | A | 0.00 | 20,000 | 0 | 384,560 | 364.6 K to 384.6 K (+5.49 %) |
Jul 01 2009 | PHLI | PACIFICHEALTH LABO ... | Ash Jason | President and CEO | Option Exercise | A | 0.28 | 200,000 | 56,000 | 200,000 | |
Jun 25 2009 | PHLI | PACIFICHEALTH LABO ... | Ash Jason | President and CEO | Buy | P | 0.28 | 267,857 | 75,000 | 647,857 | 380 K to 647.9 K (+70.49 %) |
May 20 2009 | PHLI | PACIFICHEALTH LABO ... | Ash Jason | President and CEO | Buy | P | 0.19 | 10,000 | 1,900 | 380,000 | 370 K to 380 K (+2.70 %) |
May 04 2009 | PHLI | PACIFICHEALTH LABO ... | Ash Jason | President and CEO | Buy | P | 0.20 | 12,000 | 2,400 | 370,000 | 358 K to 370 K (+3.35 %) |
Apr 06 2009 | PHLI | PACIFICHEALTH LABO ... | Mizel Adam | Director | Grant | A | 0.00 | 40,000 | 0 | 137,060 | 97.1 K to 137.1 K (+41.21 %) |
Apr 06 2009 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Director | Grant | A | 0.00 | 40,000 | 0 | 2,340,425 | 2.3 M to 2.3 M (+1.74 %) |
Apr 06 2009 | PHLI | PACIFICHEALTH LABO ... | PORTMAN DAVID I | Director | Grant | A | 0.00 | 20,000 | 0 | 519,012 | 499 K to 519 K (+4.01 %) |
Apr 06 2009 | PHLI | PACIFICHEALTH LABO ... | PARTICELLI MARC | Director | Grant | A | 0.00 | 40,000 | 0 | 216,114 | 176.1 K to 216.1 K (+22.71 %) |
Apr 06 2009 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Grant | A | 0.00 | 40,000 | 0 | 364,560 | 324.6 K to 364.6 K (+12.32 %) |
Mar 12 2009 | PHLI | PACIFICHEALTH LABO ... | Ash Jason | President and CEO | Buy | P | 0.18 | 50,000 | 9,000 | 358,000 | 308 K to 358 K (+16.23 %) |
Jan 05 2009 | PHLI | PACIFICHEALTH LABO ... | Mizel Adam | Director | Grant | A | 0.00 | 53,571 | 0 | 97,060 | 43.5 K to 97.1 K (+123.18 %) |
Jan 05 2009 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Director | Grant | A | 0.00 | 53,571 | 0 | 2,300,425 | 2.2 M to 2.3 M (+2.38 %) |
Jan 05 2009 | PHLI | PACIFICHEALTH LABO ... | PORTMAN DAVID I | Director | Grant | A | 0.00 | 53,571 | 0 | 499,012 | 445.4 K to 499 K (+12.03 %) |
Jan 05 2009 | PHLI | PACIFICHEALTH LABO ... | PORTMAN DAVID I | Director | Sell | S | 0.15 | 3,500 | 525 | 445,441 | 448.9 K to 445.4 K (-0.78 %) |
Jan 05 2009 | PHLI | PACIFICHEALTH LABO ... | PARTICELLI MARC | Director | Grant | A | 0.00 | 53,571 | 0 | 176,114 | 122.5 K to 176.1 K (+43.72 %) |
Jan 05 2009 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Grant | A | 0.00 | 53,571 | 0 | 324,560 | 271 K to 324.6 K (+19.77 %) |
Oct 03 2008 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Grant | A | 0.00 | 28,846 | 0 | 270,989 | 242.1 K to 271 K (+11.91 %) |
Oct 27 2008 | PHLI | PACIFICHEALTH LABO ... | Ash Jason | President and CEO | Buy | P | 0.30 | 200,000 | 60,000 | 241,000 | 41 K to 241 K (+487.80 %) |
Nov 12 2008 | PHLI | PACIFICHEALTH LABO ... | Ash Jason | President and CEO | Buy | P | 0.20 | 67,000 | 13,400 | 308,000 | 241 K to 308 K (+27.80 %) |
Oct 03 2008 | PHLI | PACIFICHEALTH LABO ... | PORTMAN DAVID I | Director | Grant | A | 0.00 | 28,846 | 0 | 448,941 | 420.1 K to 448.9 K (+6.87 %) |
Oct 03 2008 | PHLI | PACIFICHEALTH LABO ... | Mizel Adam | Director | Grant | A | 0.00 | 28,846 | 0 | 43,489 | 14.6 K to 43.5 K (+197.00 %) |
Oct 03 2008 | PHLI | PACIFICHEALTH LABO ... | PARTICELLI MARC | Director | Grant | A | 0.00 | 28,846 | 0 | 122,543 | 93.7 K to 122.5 K (+30.79 %) |
Oct 03 2008 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Director | Grant | A | 0.00 | 19,231 | 0 | 2,246,854 | 2.2 M to 2.2 M (+0.86 %) |
Oct 01 2008 | PHLI | PACIFICHEALTH LABO ... | Ash Jason | President and CEO | Buy | P | 0.27 | 60,000 | 16,200 | 60,000 | 0 to 60 K |
Jul 18 2008 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | CEO/CSO/CHAIRMAN | Buy | P | 0.29 | 10,000 | 2,900 | 2,270,623 | 2.3 M to 2.3 M (+0.44 %) |
Jul 18 2008 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | CEO/CSO/CHAIRMAN | Buy | P | 0.29 | 9,000 | 2,610 | 2,261,623 | 2.3 M to 2.3 M (+0.40 %) |
Jul 18 2008 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | CEO/CSO/CHAIRMAN | Buy | P | 0.32 | 25,000 | 8,000 | 2,252,623 | 2.2 M to 2.3 M (+1.12 %) |
Jul 18 2008 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | CEO/CSO/CHAIRMAN | Buy | P | 0.34 | 7,000 | 2,380 | 2,227,623 | 2.2 M to 2.2 M (+0.32 %) |
Jul 09 2008 | PHLI | PACIFICHEALTH LABO ... | PARTICELLI MARC | Director | Grant | A | 0.00 | 14,643 | 0 | 93,697 | 79.1 K to 93.7 K (+18.52 %) |
Jul 09 2008 | PHLI | PACIFICHEALTH LABO ... | Mizel Adam | Director | Grant | A | 0.00 | 14,643 | 0 | 14,643 | 0 to 14.6 K |
Jul 09 2008 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Grant | A | 0.00 | 14,643 | 0 | 242,143 | 227.5 K to 242.1 K (+6.44 %) |
Jul 09 2008 | PHLI | PACIFICHEALTH LABO ... | PORTMAN DAVID I | Director | Grant | A | 0.00 | 14,643 | 0 | 420,095 | 405.5 K to 420.1 K (+3.61 %) |
Jan 03 2008 | PHLI | PACIFICHEALTH LABO ... | PARTICELLI MARC | Director | Buy | P | 0.57 | 5,000 | 2,850 | 79,054 | 74.1 K to 79.1 K (+6.75 %) |
Dec 10 2007 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | CEO/ President/ CSO ... | Buy | P | 0.68 | 5,000 | 3,400 | 2,220,623 | 2.2 M to 2.2 M (+0.23 %) |
Dec 10 2007 | PHLI | PACIFICHEALTH LABO ... | PARTICELLI MARC | Director | Buy | P | 0.65 | 5,000 | 3,250 | 74,054 | 69.1 K to 74.1 K (+7.24 %) |
Dec 06 2007 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | CEO/ President/ CSO ... | Buy | P | 0.70 | 10,000 | 7,000 | 2,215,623 | 2.2 M to 2.2 M (+0.45 %) |
Dec 06 2007 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | CEO/ President/ CSO ... | Buy | P | 0.82 | 5,000 | 4,095 | 2,205,623 | 2.2 M to 2.2 M (+0.23 %) |
Dec 06 2007 | PHLI | PACIFICHEALTH LABO ... | PARTICELLI MARC | Director | Buy | P | 0.70 | 10,000 | 7,000 | 69,054 | 59.1 K to 69.1 K (+16.93 %) |
Dec 06 2007 | PHLI | PACIFICHEALTH LABO ... | Mizel Adam | Director | Buy | P | 0.70 | 6,000 | 4,200 | 447,780 | 441.8 K to 447.8 K (+1.36 %) |
Dec 06 2007 | PHLI | PACIFICHEALTH LABO ... | Mizel Adam | Director | Buy | P | 0.73 | 9,000 | 6,600 | 441,780 | 432.8 K to 441.8 K (+2.08 %) |
Dec 04 2007 | PHLI | PACIFICHEALTH LABO ... | PARTICELLI MARC | Director | Buy | P | 0.83 | 5,000 | 4,150 | 59,054 | 54.1 K to 59.1 K (+9.25 %) |
Dec 04 2007 | PHLI | PACIFICHEALTH LABO ... | Mizel Adam | Director | Buy | P | 0.83 | 50,000 | 41,565 | 432,780 | 382.8 K to 432.8 K (+13.06 %) |
Sep 27 2007 | PHLI | PACIFICHEALTH LABO ... | PARTICELLI MARC | Director | Option Exercise | A | 1.90 | 10,000 | 19,000 | 20,000 | |
Sep 27 2007 | PHLI | PACIFICHEALTH LABO ... | Mizel Adam | Director | Option Exercise | A | 1.90 | 10,000 | 19,000 | 20,000 | |
Aug 22 2007 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Buy | M | 0.60 | 30,000 | 18,000 | 227,500 | 197.5 K to 227.5 K (+15.19 %) |
Aug 20 2007 | PHLI | PACIFICHEALTH LABO ... | Mizel Adam | Director | Buy | P | 2.25 | 1,000 | 2,250 | 382,780 | 381.8 K to 382.8 K (+0.26 %) |
Aug 20 2007 | PHLI | PACIFICHEALTH LABO ... | Mizel Adam | Director | Buy | P | 2.20 | 2,500 | 5,500 | 381,780 | 379.3 K to 381.8 K (+0.66 %) |
Aug 15 2007 | PHLI | PACIFICHEALTH LABO ... | Mizel Adam | Director | Buy | P | 2.30 | 3,000 | 6,900 | 379,280 | 376.3 K to 379.3 K (+0.80 %) |
Aug 15 2007 | PHLI | PACIFICHEALTH LABO ... | Mizel Adam | Director | Buy | P | 2.30 | 5,000 | 11,500 | 376,280 | 371.3 K to 376.3 K (+1.35 %) |
Jan 08 2007 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | CEO/PRESIDENT/CSO/C ... | Buy | P | 0.95 | 100,000 | 95,000 | 2,200,623 | 2.1 M to 2.2 M (+4.76 %) |
Jan 08 2007 | PHLI | PACIFICHEALTH LABO ... | PORTMAN DAVID T | Director | Buy | P | 0.95 | 100,000 | 95,000 | 405,452 | 305.5 K to 405.5 K (+32.74 %) |
Jan 08 2007 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Buy | P | 0.95 | 100,000 | 95,000 | 197,500 | 97.5 K to 197.5 K (+102.56 %) |
Dec 15 2006 | PHLI | PACIFICHEALTH LABO ... | KUCHEN STEPHEN P | VP-FINANCE/CFO | Option Exercise | A | 1.13 | 50,000 | 56,500 | 50,000 | |
Dec 15 2006 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | CEO/PRESIDENT/CSO/C ... | Option Exercise | A | 1.13 | 275,000 | 310,750 | 275,000 | |
Dec 15 2006 | PHLI | PACIFICHEALTH LABO ... | PORTMAN DAVID T | Director | Option Exercise | A | 1.13 | 40,000 | 45,200 | 40,000 | |
Dec 15 2006 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Option Exercise | A | 1.13 | 40,000 | 45,200 | 40,000 | |
Jun 12 2006 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Buy | M | 0.85 | 10,000 | 8,500 | 97,500 | 87.5 K to 97.5 K (+11.43 %) |
Jun 12 2006 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Buy | M | 0.72 | 50,000 | 36,000 | 87,500 | 37.5 K to 87.5 K (+133.33 %) |
Apr 05 2006 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | CEO/President/CSO/C ... | Option Exercise | M | 1.00 | 100,000 | 100,000 | 0 | |
Apr 05 2006 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | CEO/President/CSO/C ... | Buy | M | 1.00 | 100,000 | 100,000 | 2,100,623 | 2 M to 2.1 M (+5.00 %) |
Mar 08 2006 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Buy | P | 0.98 | 15,000 | 14,700 | 37,500 | 22.5 K to 37.5 K (+66.67 %) |
Feb 23 2006 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Buy | P | 0.88 | 22,500 | 19,825 | 22,500 | 0 to 22.5 K |
Feb 15 2006 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Option Exercise | A | 0.60 | 30,000 | 18,000 | 30,000 | |
Feb 15 2006 | PHLI | PACIFICHEALTH LABO ... | PORTMAN DAVID T | Director | Option Exercise | A | 0.60 | 30,000 | 18,000 | 30,000 | |
Feb 15 2006 | PHLI | PACIFICHEALTH LABO ... | KUCHEN STEPHEN P | VP-Finance/CFO | Option Exercise | A | 0.60 | 100,000 | 60,000 | 100,000 | |
Feb 15 2006 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | CEO/President/CSO/C ... | Option Exercise | A | 0.60 | 300,000 | 180,000 | 300,000 | |
Jan 05 2006 | PHLI | PACIFICHEALTH LABO ... | PORTMAN DAVID T | Director | Option Exercise | M | 0.31 | 10,000 | 3,100 | 0 | |
Jan 05 2006 | PHLI | PACIFICHEALTH LABO ... | PORTMAN DAVID T | Director | Buy | M | 0.31 | 10,000 | 3,100 | 305,452 | 295.5 K to 305.5 K (+3.38 %) |
Jan 05 2006 | PHLI | PACIFICHEALTH LABO ... | KUCHEN STEPHEN P | VP-Finance/CFO | Option Exercise | M | 0.31 | 10,000 | 3,100 | 0 | |
Jan 05 2006 | PHLI | PACIFICHEALTH LABO ... | KUCHEN STEPHEN P | VP-Finance/CFO | Buy | M | 0.31 | 10,000 | 3,100 | 20,696 | 10.7 K to 20.7 K (+93.49 %) |
Jan 05 2006 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | CEO/President/CSO/C ... | Option Exercise | M | 0.31 | 460,000 | 142,600 | 0 | |
Jan 05 2006 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | CEO/President/CSO/C ... | Buy | M | 0.31 | 460,000 | 142,600 | 2,000,623 | 1.5 M to 2 M (+29.86 %) |
Feb 09 2005 | PHLI | PACIFICHEALTH LABO ... | HORN GREGORY THOMAS | Director | Sell | S | 0.71 | 102,340 | 72,661 | 475,467 | 577.8 K to 475.5 K (-17.71 %) |
Sep 23 2004 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Option Exercise | A | 0.72 | 25,000 | 18,000 | 25,000 | |
Sep 23 2004 | PHLI | PACIFICHEALTH LABO ... | CAHR MICHAEL E | Director | Option Exercise | A | 0.72 | 25,000 | 18,000 | 25,000 | |
Sep 23 2004 | PHLI | PACIFICHEALTH LABO ... | HARRIS JOSEPH L | Director | Option Exercise | A | 0.72 | 25,000 | 18,000 | 25,000 | |
Sep 23 2004 | PHLI | PACIFICHEALTH LABO ... | HARRIS JOSEPH L | Director | Option Exercise | A | 0.72 | 25,000 | 18,000 | 25,000 | |
Sep 23 2004 | PHLI | PACIFICHEALTH LABO ... | PORTMAN DAVID T | Director | Option Exercise | A | 0.72 | 15,000 | 10,800 | 15,000 | |
Sep 23 2004 | PHLI | PACIFICHEALTH LABO ... | HORN GREGORY THOMAS | Director | Option Exercise | A | 0.72 | 15,000 | 10,800 | 15,000 | |
Sep 03 2004 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Chairman and CSO | Option Exercise | A | 0.65 | 150,000 | 97,500 | 150,000 | |
Sep 03 2004 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Chairman and CSO | Option Exercise | A | 0.65 | 150,000 | 97,500 | 150,000 | |
Sep 03 2004 | PHLI | PACIFICHEALTH LABO ... | PORTMAN ROBERT | Chairman and CSO | Option Exercise | A | 0.65 | 150,000 | 97,500 | 150,000 |
Page: 1